Enzyme-containing compositions, dietetic foods and pharmaceuticals made therefrom and their use for medical purposes
DE10018980A1
Prophylaxis and therapy of diabetes mellitus I using proteolytic enzymes
DE19957318A1
Influence of TGF-beta by proteolytic enzymes
DE19847114A1
Use of proteolytic enzymes to modulate hyperactive T cells, especially for symptomatic treatment of immune-mediated inflammatory diseases, e.g. multiple sclerosis, diabetes, arthritis or glomerulonephritis
DE19804742A1
Treatment of hepatitis C virus infection and associated liver cancer with hydrolytic enzyme and flavonoid
DE19726244A1
Use of proteolytic enzymes and rutoside to prevent or treat graft rejection
DE19726254A1
Tolerance induction through proteases
DE19726253A1
Use of at least one proteolytic enzyme and rutoside for the treatment of glomerulonephritis
DE19726248A1
Use of proteolytic enzymes and rutoside to treat septic shock
DE19726251A1
Use of proteolytic enzymes for the treatment of uveitis
DE19726255A1
Influence of cytokines by proteolytic enzymes and rutoside
DE19724458A1
Use of proteolytic enzymes e.g., trypsin, bromelain or papain
DE4336343A1
Use of proteolytic enzymes for abort prophylaxis in pregnant women with a history of idiopathic abortus habitualis
DE4302060A1
Use of bromelain as CD44 surface molecule modifier
EP0309602A1
Use of catabolic enzymes for the manufacture of a medicament in the treatment of AIDS and its early stages (LAS, ARC)
DE3724890A1
Process for producing a preparation with an oil-in-water emulsion
